These exclude many patients, including Medicare and Medicaid enrollees
Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, dyslipidemia, obstructive sleep apnea or cardiovascular disease)
They use Noom Move workouts an average of 6.9 times in the first month and 45% engage with side-effect support in Nooms Success Kit. Upcoming webinars The science of HMOs A novonesis webinar featuring new clinical findings and ESPGHAN highlights Novonesis From boosters to companions: GLP-1 in Food, Beverages and Supplements Rousselot Top Nutrition Trends 2027 Nutrition Insight
Both medications require gradual titration over 3-5 months before reaching maintenance doses
Soluble fiber sources include oats, barley, apples, citrus fruits, carrots, and legumes such as lentils and black beans
This consistency between claims and ingredients signals a thoughtful approach rather than hype